Centessa Pharmaceuticals (uk) Limited

This early-stage study tested a new drug called LB101 in 25 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The trial was terminated early, so results are limited and no clear benefit…